This leads to the conclusion that using a drug to lose weight is somehow cheating, or taking the easy way out, and we shouldnt be spending NHS money on something people could fix themselves
Off-Label Uses Sometimes, doctors might use semaglutide for other conditions, not just diabetes or obesity
Marc Dunoyer, the companys rare disease head, in a statement called Ultomiris a transformative treatment option for NMOSD, with the potential to eliminate relapses with a convenient dosing schedule every eight weeks. The approval was backed by data from a Phase III trial that met its primary efficacy endpoint, preventing relapse in all 58 treated patients over a median of 73.5 weeks, compared to 20 relapses in the placebo arm of a trial for AstraZenecas other NMOSD therapy Soliris
Skov J, Dejgaard A, Frokiaer J, Holst JJ, Jonassen T, Rittig S, et al